Work

P03-019 - Anakinra for sweet syndrome treatment

Year: 2013
Type: article
Study design: Case Report
Abstract: Sweet syndrome (SS) is a rare autoinflamamtory neutrophilic dermatosis, sometimes associated with hematologic malignancies. We describe two cases of SS related to hematologic diseases successfully treated with an interleukin-1 (IL-1) receptor antagonist (Anakinra).
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W2015488917
FWCI:
Cites: 4
Cited by: 2
Related to: 10